Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there are a number of companies that claim to offer end-to-end solutions, ranging from antibody development to commercial production. Further, prevalent trends suggest that sponsor companies are likely to continue relying on contract service providers for various aspects of antibody-based product development and manufacturing.


To order this 285+ page report, which features 100+ figures and 110+ tables, please visit


The USD 17 billion (by 2030) financial opportunity within the antibody contract manufacturing market has been analyzed across the following segments:

§  Type of Antibodies

§  Monoclonal Antibodies

§  Bispecific Antibodies

§  ADCs

§  Others


§  Company Size

§  Small

§  Mid-sized

§  Large / Very Large


§  Scale of Operation

§  Preclinical / Clinical

§  Commercial


§  Type of expression system used

§  Mammalian

§  Microbial


§  Key geographical regions

§  North America

§  Europe

§  Asia and RoW


The Antibody Contract Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: 

§  AGC Biologics

§  Aldevron


§  Boehringer Ingelheim BioXcellence

§  Emergent BioSolutions

§  Eurofins CDMO

§  FUJIFILM Diosynth Biotechnologies

§  KBI Biopharma

§  Lonza

§  Nitto Avecia Pharma Services

§  Novasep

§  Pierre Fabre

§  Samsung BioLogics

§  Synthon

§  Thermo Fisher Scientific


Table of Contents


1. Preface


2. Executive Summary


3. Introduction


4. Market Landscape


5. Company Competitive Analysis


6. Company Profiles


7. Case Study: Comparison of Small and Large Molecules (Biologics) Drugs / Therapies


8. Benchmark Analysis


9. Partnerships


10. Recent Expansions


11. Capacity Analysis


12. Demand Analysis


13. Market Sizing and Opportunity Analysis


14. SWOT Analysis


15. Future of The Antibody CMO Market


16. Interview Transcripts


17. Appendix 1: List of Antibody Custom Manufacturers


18. Appendix 2: Tabulated Data


19. Appendix 3: List of Companies and Organizations

To purchase a copy, please visit


About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]


Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Facebook –

LinkedIn –

Twitter –

Medium –


Pinterest –

Quora –